ClinicalTrials.Veeva

Menu

Impact of Acquired FXIII Deficiency on Morbidity and Mortality

P

Patricia Duque González

Status

Completed

Conditions

Acquired Factor XIII Deficiency Disease

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality

Full description

All patients admitted to a large tertiary hospital with FXIII levels below 70% during their hospital stay are assessed. Data regarding patient background, blood transfusion, morbidity and mortality is registered.

Enrollment

50 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • FXIII levels < 70%

Exclusion criteria

  • None

Trial design

50 participants in 1 patient group

Factor XIII deficiency
Description:
Patients admitted to hospital with FXIII levels below 70% during their hospital stay
Treatment:
Other: Data collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems